UY27334A1 - Formulaciones de lactonas y método de uso de las mismas - Google Patents
Formulaciones de lactonas y método de uso de las mismasInfo
- Publication number
- UY27334A1 UY27334A1 UY27334A UY27334A UY27334A1 UY 27334 A1 UY27334 A1 UY 27334A1 UY 27334 A UY27334 A UY 27334A UY 27334 A UY27334 A UY 27334A UY 27334 A1 UY27334 A1 UY 27334A1
- Authority
- UY
- Uruguay
- Prior art keywords
- cancer
- treatment
- compounds
- lactone structure
- lactons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/58—One oxygen atom, e.g. butenolide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Furan Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Compuestos de las fórmulas la Ic: que tienen una estructura lactona y un grupo metileno en la posición alfa de la estructura lactona y métodos para utilizar y elaborar los compuestos. Las lactonas son de utilidad en el tratamiento de trastornos proliferativos incluyendo, por ejemplo, cáncer de mama, cáncer de colon, cáncer rectal, cáncer de estómago, cáncer de pulmón, cáncer de hígado, cáncer de ovario, cáncer de esófago y leucemia. También son efectivas en el tratamiento de infecciones bacterianas y fúngicas, incluyendo el tratamiento de úlceras pépticas, gingivitis y periodontitis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29787501P | 2001-06-13 | 2001-06-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27334A1 true UY27334A1 (es) | 2003-02-28 |
Family
ID=23148076
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27334A UY27334A1 (es) | 2001-06-13 | 2002-06-13 | Formulaciones de lactonas y método de uso de las mismas |
Country Status (21)
Country | Link |
---|---|
US (3) | US6900242B2 (es) |
EP (1) | EP1406895B1 (es) |
JP (1) | JP2005500289A (es) |
KR (1) | KR20040030676A (es) |
AR (1) | AR036056A1 (es) |
AT (1) | ATE406367T1 (es) |
AU (1) | AU2002306150B2 (es) |
BR (1) | BR0210432A (es) |
CA (1) | CA2450660C (es) |
CO (1) | CO5550429A2 (es) |
CY (1) | CY1108590T1 (es) |
DE (1) | DE60228576D1 (es) |
DK (1) | DK1406895T3 (es) |
ES (1) | ES2315365T3 (es) |
IL (3) | IL159296A0 (es) |
MX (1) | MXPA03011554A (es) |
PT (1) | PT1406895E (es) |
RS (1) | RS52139B (es) |
UY (1) | UY27334A1 (es) |
WO (1) | WO2002100854A1 (es) |
ZA (1) | ZA200400208B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1406895E (pt) * | 2001-06-13 | 2008-11-04 | Magnachem Int Lab Inc | Formulações de lactonas e métodos para o seu uso |
US8188145B2 (en) * | 2002-06-12 | 2012-05-29 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations and method of use |
MXPA05004794A (es) * | 2002-11-05 | 2005-08-19 | Magnachem Int Lab Inc | Formulaciones de lactonas y metodos de uso. |
US20050045197A1 (en) * | 2003-08-28 | 2005-03-03 | Gelder Steven K. | Multiple drug delivery system & method |
KR20110128785A (ko) * | 2008-10-24 | 2011-11-30 | 매그나켐 인터내셔널 레버러토리즈 아이엔씨 | Rad9와 선택적으로 상호작용하는 화합물들의 스크리닝방법 |
CN103099901B (zh) * | 2013-01-26 | 2014-07-30 | 张红 | 一种治疗子宫内膜移位症的中药灌肠剂 |
KR101988479B1 (ko) * | 2017-10-11 | 2019-09-24 | (주)휴럼 | 리트세노라이드를 유효성분으로 하는 헬리코박터 파이로리 균주로부터 유래되는 위장질환 예방 및 치료용 약학 조성물 |
Family Cites Families (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2624723A (en) * | 1947-03-03 | 1953-01-06 | Allied Chem & Dye Corp | Lactone derivatives and method of making |
US2624732A (en) * | 1950-05-10 | 1953-01-06 | Burroughs Wellcome Co | Preparation of 5-benzyl-2,4-diaminopyrimidines |
US3203953A (en) * | 1963-01-18 | 1965-08-31 | Ciba Geigy Corp | Lactone obtained from helenium sp. and derivatives thereof |
US3210377A (en) * | 1963-06-05 | 1965-10-05 | Olin Mathieson | Gamma lactones |
US4001425A (en) * | 1974-04-17 | 1977-01-04 | E. I. Du Pont De Nemours And Company | Methods of treating hypertension and pharmaceutical compositions comprising 1-tertiary-alkyl-3-(substituted furyl)ureas as antihypertensive agents |
JPS5111173B2 (es) * | 1974-04-25 | 1976-04-09 | ||
JPS51125722A (en) | 1975-01-13 | 1976-11-02 | Sumitomo Chem Co Ltd | Germicides for industry and their preparation |
JPS597713B2 (ja) | 1977-12-19 | 1984-02-20 | 三井東圧化学株式会社 | 新規γ↓−ブチロラクトン誘導体とその製造法 |
JPS56128776A (en) | 1980-03-14 | 1981-10-08 | Otsuka Pharmaceut Factory Inc | Alpha-methylene gamma-butyrolactone derivative |
JPS58199413A (ja) | 1982-05-13 | 1983-11-19 | Pioneer Electronic Corp | デイジタル変調信号の読取装置 |
JPS6058973A (ja) * | 1983-09-13 | 1985-04-05 | Mitsubishi Yuka Yakuhin Kk | γ−プチロラクトン誘導体及びそれを有効成分とする免疫調節剤 |
JPS6226221A (ja) | 1985-07-29 | 1987-02-04 | Japan Tobacco Inc | 抗変異原性剤 |
JP2524760B2 (ja) | 1987-07-10 | 1996-08-14 | テイカ株式会社 | 新規抗生物質 |
JPH01163175A (ja) | 1987-12-21 | 1989-06-27 | Ss Pharmaceut Co Ltd | フラン−2−オン誘導体 |
US5242945A (en) * | 1991-04-12 | 1993-09-07 | American Home Products Corporation | Tetronic and thiotetronic acid derivatives as phospholipase a2 inhibitors |
US5250735A (en) * | 1992-04-03 | 1993-10-05 | University Of Pittsburgh | 2-(N-substituted-aminoalkyl)-5-(E)-alkylidene cyclopentanones, 2-(N-substituted-aminoalkyl)-5-(E)-arylalkylidene cyclopentanones, and derivatives thereof |
EP0720607A1 (en) * | 1993-09-17 | 1996-07-10 | PHARMACIA & UPJOHN COMPANY | Substituted tetronic acids useful for treating hiv and other retroviruses |
US5595756A (en) * | 1993-12-22 | 1997-01-21 | Inex Pharmaceuticals Corporation | Liposomal compositions for enhanced retention of bioactive agents |
ATE201397T1 (de) | 1994-06-07 | 2001-06-15 | Teijin Ltd | Vitamin d3 derivate und ein verfahren zu ihrer herstellung |
AUPN191295A0 (en) | 1995-03-23 | 1995-04-27 | Unisearch Limited | Microbiocide or microbial regulator |
US5962460A (en) * | 1995-06-27 | 1999-10-05 | National Science Council (Taiwan) | Antineoplastic α-methylene-γ-butyrolactones |
US5646164A (en) * | 1995-11-14 | 1997-07-08 | National Science Council | α-methylene-γ-butyrolactones: new inhibitors of platelet aggregation |
DK0869784T3 (da) | 1995-11-17 | 2006-01-16 | Univ Johns Hopkins | Hæmning af fedtsyresyntase som middel til formindskelse af adipocytmængden |
US6222048B1 (en) * | 1995-12-18 | 2001-04-24 | Merck Frosst Canada & Co. | Diaryl-2-(5H)-furanones as Cox-2 inhibitors |
US5618835A (en) | 1996-02-01 | 1997-04-08 | The Procter & Gamble Company | Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
US6180651B1 (en) * | 1996-04-04 | 2001-01-30 | Bristol-Myers Squibb | Diarylmethylidenefuran derivatives, processes for their preparation and their uses in therapeutics |
US5981575A (en) * | 1996-11-15 | 1999-11-09 | Johns Hopkins University, The | Inhibition of fatty acid synthase as a means to reduce adipocyte mass |
US5939455A (en) | 1997-03-11 | 1999-08-17 | Beacon Laboratories, Inc. | Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives |
EP0971910A1 (en) | 1997-04-02 | 2000-01-19 | Merck Frosst Canada & Co. | Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
US5905089A (en) * | 1997-04-14 | 1999-05-18 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of sesquiterpene lactones for treatment of severe inflammatory disorders |
AUPP303498A0 (en) | 1998-04-17 | 1998-05-14 | Unisearch Limited | Inhibition of gram positive bacteria |
US6395724B1 (en) * | 1998-06-08 | 2002-05-28 | Advanced Medicine, Inc. | Multibinding inhibitors of cyclooxygenase-2 |
JP2002540200A (ja) * | 1999-03-30 | 2002-11-26 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | α−メチレンラクトンの製造方法 |
FR2801792B1 (fr) | 1999-12-01 | 2003-04-18 | Sod Conseils Rech Applic | Un nouveau medicament, le dihydromikanolide, son obtention par extraction de la plante mikania micrantha et son utilisation comme agent anti-proliferatif |
US6660511B1 (en) | 2000-03-03 | 2003-12-09 | Rigel Pharmaceuticals, Inc. | Methods of screening for modulation of cell cycle |
AU2001258677A1 (en) * | 2000-05-22 | 2001-12-03 | Dr. Reddy's Research Foundation | Novel compounds having antiinflammatory activity: process for their preparation and pharmaceutical compositions containing them |
JP2002037797A (ja) * | 2000-07-25 | 2002-02-06 | Kanegafuchi Chem Ind Co Ltd | マクロファージ選択的細胞死誘導物質 |
CA2433785C (en) | 2001-01-12 | 2009-08-04 | Michael Dewitt Culler | Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
PT1406895E (pt) * | 2001-06-13 | 2008-11-04 | Magnachem Int Lab Inc | Formulações de lactonas e métodos para o seu uso |
US6686724B2 (en) * | 2002-05-21 | 2004-02-03 | Ford Motor Company | Method of and apparatus for controlling charging and/or discharging of a battery for a hybrid electric vehicle |
US8188145B2 (en) * | 2002-06-12 | 2012-05-29 | Magnachem International Laboratories, Inc. | Synthetic lactone formulations and method of use |
MXPA05004794A (es) * | 2002-11-05 | 2005-08-19 | Magnachem Int Lab Inc | Formulaciones de lactonas y metodos de uso. |
-
2002
- 2002-06-12 PT PT02734779T patent/PT1406895E/pt unknown
- 2002-06-12 WO PCT/US2002/018602 patent/WO2002100854A1/en active Application Filing
- 2002-06-12 JP JP2003503621A patent/JP2005500289A/ja active Pending
- 2002-06-12 BR BR0210432-6A patent/BR0210432A/pt not_active IP Right Cessation
- 2002-06-12 US US10/172,462 patent/US6900242B2/en not_active Expired - Lifetime
- 2002-06-12 AU AU2002306150A patent/AU2002306150B2/en not_active Ceased
- 2002-06-12 IL IL15929602A patent/IL159296A0/xx unknown
- 2002-06-12 KR KR10-2003-7016356A patent/KR20040030676A/ko active Search and Examination
- 2002-06-12 ES ES02734779T patent/ES2315365T3/es not_active Expired - Lifetime
- 2002-06-12 AT AT02734779T patent/ATE406367T1/de active
- 2002-06-12 DE DE60228576T patent/DE60228576D1/de not_active Expired - Lifetime
- 2002-06-12 RS YU98603A patent/RS52139B/en unknown
- 2002-06-12 MX MXPA03011554A patent/MXPA03011554A/es active IP Right Grant
- 2002-06-12 EP EP02734779A patent/EP1406895B1/en not_active Expired - Lifetime
- 2002-06-12 DK DK02734779T patent/DK1406895T3/da active
- 2002-06-12 CA CA2450660A patent/CA2450660C/en not_active Expired - Fee Related
- 2002-06-13 AR ARP020102236A patent/AR036056A1/es not_active Application Discontinuation
- 2002-06-13 UY UY27334A patent/UY27334A1/es not_active Application Discontinuation
-
2003
- 2003-12-10 IL IL159296A patent/IL159296A/en not_active IP Right Cessation
-
2004
- 2004-01-09 CO CO04001331A patent/CO5550429A2/es not_active Application Discontinuation
- 2004-01-12 ZA ZA2004/00208A patent/ZA200400208B/en unknown
-
2005
- 2005-05-26 US US11/139,338 patent/US20050209316A1/en not_active Abandoned
-
2008
- 2008-11-24 CY CY20081101353T patent/CY1108590T1/el unknown
-
2010
- 2010-12-15 US US12/968,508 patent/US8536348B2/en not_active Expired - Fee Related
-
2011
- 2011-03-27 IL IL211958A patent/IL211958A0/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20040030676A (ko) | 2004-04-09 |
EP1406895B1 (en) | 2008-08-27 |
RS52139B (en) | 2012-08-31 |
US20050209316A1 (en) | 2005-09-22 |
AU2002306150B2 (en) | 2008-02-14 |
US20110092588A1 (en) | 2011-04-21 |
EP1406895A4 (en) | 2004-11-17 |
BR0210432A (pt) | 2004-08-03 |
DK1406895T3 (da) | 2008-12-01 |
CY1108590T1 (el) | 2014-04-09 |
DE60228576D1 (de) | 2008-10-09 |
PT1406895E (pt) | 2008-11-04 |
US6900242B2 (en) | 2005-05-31 |
EP1406895A1 (en) | 2004-04-14 |
IL159296A (en) | 2011-06-30 |
US20030069393A1 (en) | 2003-04-10 |
JP2005500289A (ja) | 2005-01-06 |
WO2002100854A1 (en) | 2002-12-19 |
CA2450660A1 (en) | 2002-12-19 |
CA2450660C (en) | 2011-08-16 |
IL211958A0 (en) | 2011-06-30 |
AR036056A1 (es) | 2004-08-04 |
ZA200400208B (en) | 2005-06-29 |
US8536348B2 (en) | 2013-09-17 |
CO5550429A2 (es) | 2005-08-31 |
ATE406367T1 (de) | 2008-09-15 |
RS98603A (en) | 2006-12-15 |
ES2315365T3 (es) | 2009-04-01 |
IL159296A0 (en) | 2004-06-01 |
MXPA03011554A (es) | 2004-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108549T1 (el) | Συνθετικες μεθοδοι για απλιδινη και νεα κατα του ογκου παραγωγα, μεθοδοι κατασκευης και χρησης αυτων | |
BR0014352A (pt) | Cetoenóis espirocìclicos substituìdos por trifluormetila | |
CY1105386T1 (el) | Βενζοϋλοσουλφοναμιδια και σουλφονυλβενζαμιδινες για χρηση σαν παραγοντες κατα του ογκου | |
CY1109886T1 (el) | Καινοφανεις ενωσεις ως αντι-φλεγμονωδεις, ανοσοτροποποιητικοι και αντι υπερπλαστικοι παραγοντες | |
UY30030A1 (es) | Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones | |
CY1110000T1 (el) | Ενωσεις οκταϋδροβενζιμιδαζολονης ως αναλγητικα | |
CY1105387T1 (el) | Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου | |
CY1105247T1 (el) | Υποκατεστημενα παραγωγα c- κυκλοεξυλομεθυλαμινης | |
CY1108793T1 (el) | Καμπτοθεκινες με τροποποιημενο λακτονικο δακτυλιο | |
CY1105275T1 (el) | Ενωσεις υποκατεστημενης γ-λακτονης ως ανταγωνισται - νμda | |
HRPK20030734B3 (en) | A combination comprising combretastatin and anticancer agents | |
MXPA04009283A (es) | Nuevos derivados de alcoxipiridina. | |
UY27334A1 (es) | Formulaciones de lactonas y método de uso de las mismas | |
ATE311389T1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
DE60204701D1 (de) | Tricyclische imidazopyridine | |
WO2004098524A3 (en) | Lipid platinum complexes and methods of use thereof | |
DE60127131D1 (de) | Tricyclische imidazopyridine | |
CY1105345T1 (el) | Φαινυλαλκινια | |
CY1106376T1 (el) | Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν | |
DE60231426D1 (de) | Solubilisierte topoisomerase-gift-mittel | |
TR200402030T4 (tr) | İkame edilen I-aminobutan-3-ol-türevleri | |
ATE298328T1 (de) | Taxan-derivate für die behandlung von krebs | |
EA200600092A1 (ru) | Новые цитотоксические депсипептиды | |
ES2078501T3 (es) | Metodo para el tratamiento de la trombocitopenia y composiciones farmaceuticas utiles para el mismo. | |
ATE460168T1 (de) | Nicht-radioaktives strontiummittel zur behandlung von krebs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20141124 |